Evidence map›Paper›PMID 34716321›Full record

ArticleNature communications2021

Inner nuclear protein Matrin-3 coordinates cell differentiation by stabilizing chromatin architecture.

Hye Ji Cha, Özgün Uyan, Yan Kai, Tianxin Liu, Qian Zhu, Zuzana Tothova, Giovanni A Botten, Jian Xu, Guo-Cheng Yuan, Job Dekker and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Sustainable integrative cell biology: CENP-C is guilty by association.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Erythropoiesis: insights from a genomic perspective.Experimental & molecular medicine · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Asymmetric scapuloperoneal phenotype ofFrontiers in genetics · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Hye Ji ChaDivision of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute (DFCI), Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Özgün Uyan *Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.
Yan Kai *Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3262-4160
Tianxin LiuDivision of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute (DFCI), Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Qian ZhuDivision of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute (DFCI), Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7062-8221
Zuzana TothovaDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Giovanni A BottenChildren's Medical Center Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-8054-8030
Jian XuChildren's Medical Center Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0003-1988-7337
Guo-Cheng YuanDepartment of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Job DekkerProgram in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0001-5631-0698
Stuart H OrkinDivision of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute (DFCI), Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA. stuart_orkin@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-0313-152X
Boston Children's Hospital · USChildren's Medical Center · USHarvard University · USHoward Hughes Medical Institute · USBroad Institute · USUniversity of Massachusetts Chan Medical School · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI YIEN, YVETTE Y · 1985 to 2021
$38.9M
MOLECULAR ANALYSIS OF NORMAL AND TYHALASSEMIC DNAR01HL032259 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2022
$8.8M
Molecular Analysis of Transcriptional Enhancers in HematopoiesisR01DK111430 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jian Xu · 2016 to 2026
$4.8M
Systems Biology Analysis of Human ErythropoiesisR01HL119099 · NHLBI · DANA-FARBER CANCER INST · PI ORKIN, STUART H, YUAN, GUO-CHENG · 2014 to 2018
$3.4M
A systems biology approach for dissecting enhancer hierarchyR01HG009663 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YUAN, GUO-CHENG · 2017 to 2020
$2.8M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Targeting Metabolic Liabilities of Leukemia-Initiating Cells (R01CA230631)R01CA230631 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XU, JIAN · 2019 to 2023
$1.8M
Investigating the Mechanisms of Cohesinopathy in Myelodysplastic SyndromesK08HL140138 · NHLBI · DANA-FARBER CANCER INST · PI TOTHOVA, ZUZANA · 2018 to 2020
$444k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA230631NHGRI NIH HHS R01 HG009663NHLBI NIH HHS K08 HL140138NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL119099NIDDK NIH HHS R01 DK111430NIH HHS S10 OD026880
6 · The paper itself

Abstract

Precise control of gene expression during differentiation relies on the interplay of chromatin and nuclear structure. Despite an established contribution of nuclear membrane proteins to developmental gene regulation, little is known regarding the role of inner nuclear proteins. Here we demonstrate that loss of the nuclear scaffolding protein Matrin-3 (Matr3) in erythroid cells leads to morphological and gene expression changes characteristic of accelerated maturation, as well as broad alterations in chromatin organization similar to those accompanying differentiation. Matr3 protein interacts with CTCF and the cohesin complex, and its loss perturbs their occupancy at a subset of sites. Destabilization of CTCF and cohesin binding correlates with altered transcription and accelerated differentiation. This association is conserved in embryonic stem cells. Our findings indicate Matr3 negatively affects cell fate transitions and demonstrate that a critical inner nuclear protein impacts occupancy of architectural factors, culminating in broad effects on chromatin organization and cell differentiation.

Indexed as

AnimalsCCCTC-Binding FactorCell Cycle ProteinsCell DifferentiationCell NucleusChromatinChromosomal Proteins, Non-HistoneCohesinsEmbryonic Stem CellsErythroid CellsLeukemia, Erythroblastic, AcuteMiceMice, KnockoutNuclear Matrix-Associated ProteinsRNA-Binding ProteinsCCCTC-Binding FactorCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsCtcf protein, mousematrin-3 protein, mouseNuclear Matrix-Associated ProteinsRNA-Binding Proteins

Identifiers

PMID34716321
PMCPMC8556400
OpenAlexW3208292419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.